Where Will RocketLab Stock Be In 5 Years?
Rocket Lab (NASDAQ: RKLB) closed recently at around $30 per share,…
Sell
36
DSKYF Quote, Financials, Valuation and Earnings
Last price:
$23.13
Seasonality move
:
10.37%
Day range:
$22.16 - $24.19
52-week range:
$20.15 - $44.64
Dividend yield:
1.75%
P/E ratio:
22.33x
P/S ratio:
3.50x
P/B ratio:
3.98x
Volume:
7K
Avg. volume:
27.9K
1-year change:
-33.11%
Market cap:
$43.2B
Revenue:
$12.4B
EPS (TTM):
$1.04
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Daiichi Sankyo has -- downside to fair value with a price target of -- per share.
DSKYF vs. S&P 500
-
Over the past 5 trading days, Daiichi Sankyo has underperformed the S&P 500 by -11.01% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Daiichi Sankyo does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Daiichi Sankyo has grown year-over-year revenues for 7 quarters straight. In the most recent quarter Daiichi Sankyo reported revenues of $3.2B.
Earnings Growth
-
Daiichi Sankyo earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Daiichi Sankyo reported earnings per share of $0.21.
Enterprise value:
39.1B
EV / Invested capital:
3.39x
Price / LTM sales:
3.50x
EV / EBIT:
15.98x
EV / Revenue:
3.12x
PEG ratio (5yr expected):
1.21x
EV / Free cash flow:
13.51x
Price / Operating cash flow:
19.96x
Enterprise value / EBITDA:
13.47x
Gross Profit (TTM):
$9.8B
Return On Assets:
8.51%
Net Income Margin (TTM):
15.69%
Return On Equity:
17.67%
Return On Invested Capital:
16.65%
Operating Margin:
12.67%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $9B | $10.7B | $11.7B | $3B | $3.2B | |
| Gross Profit | $6.3B | $7.7B | $8.7B | $2.2B | $2.3B | |
| Operating Income | $495.3M | $1.3B | $1.5B | $673.8M | $402.6M | |
| EBITDA | $1.1B | $2B | $2.2B | $841.3M | $605.4M | |
| Diluted EPS | $0.21 | $0.68 | $0.72 | $0.23 | $0.21 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $11.5B | $11B | $11.2B | $14.4B | $12.8B | |
| Total Assets | $18.9B | $18.2B | $18.8B | $22.9B | $23.1B | |
| Current Liabilities | $3.2B | $3.2B | $4B | $4.8B | $5B | |
| Total Liabilities | $7.4B | $7.1B | $8B | $11.7B | $12.2B | |
| Total Equity | $11.5B | $11.1B | $10.9B | $11.2B | $10.8B | |
| Total Debt | $1.7B | $1.3B | $1.1B | $672M | $677.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2023-03-31 | 2024-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.2B | $848M | $4.2B | $265.4M | $297.2M | |
| Cash From Investing | $1.9B | -$1.9B | -$2B | $45M | -$473.9M | |
| Cash From Financing | -$768.1M | -$663.5M | -$856.3M | -$54.9M | -$45.4M | |
| Free Cash Flow | $557.1M | $349.2M | $3.3B | $125.4M | -$43M | |
DSKYF
Sector
Market Cap
$43.2B
$32.8M
Price % of 52-Week High
51.8%
46.28%
Dividend Yield
1.75%
0%
Shareholder Yield
1.3%
-0.74%
1-Year Price Total Return
-33.11%
-35.38%
Beta (5-Year)
0.494
0.632
Dividend yield:
1.75%
Annualized payout:
$0.41
Payout ratio:
--
Growth streak:
2 years
Technicals
8-day SMA
Sell
Level
$24.09
200-day SMA
Sell
Level
$27.94
Bollinger Bands (100)
Sell
Level
22.47 - 26.11
Chaikin Money Flow
Sell
Level
-264.5K
20-day SMA
Sell
Level
$25.08
Relative Strength Index (RSI14)
Sell
Level
46.38
ADX Line
Sell
Level
9.55
Williams %R
Buy
Level
-85.8696
50-day SMA
Sell
Level
$24.36
MACD (12, 26)
Sell
Level
-0.21
25-day Aroon Oscillator
Buy
Level
32
On Balance Volume
Sell
Level
-15.8K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.8877)
Buy
CA Score
(Annual)
Level (0.1215)
Sell
Beneish M-Score
(Annual)
Level (-1.7769)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-1.6444)
Buy
Piotroski F Score
(Annual)
Level (7)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2021, approximately half of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates. Its three lead ADCs are Enhertu (HER2), Dato-DXd (TROP2), and HER3-DXd (HER3). Enhertu entered the clinic in 2015 and received its first U.S Food and Drug Administration approval in December 2019 for third-line late-stage HER2-positive breast cancer and its high efficacy is changing the treatment landscape for HER-expressing breast cancers. It is also approved for HER2-positive stomach cancers and HER2 mutant non-small cell lung cancer.
Stock Forecast FAQ
In the current month, DSKYF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The DSKYF average analyst price target in the past 3 months is --.
-
Where Will Daiichi Sankyo Stock Be In 1 Year?
According to analysts, the consensus estimate is that Daiichi Sankyo share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Daiichi Sankyo?
Analysts are divided on their view about Daiichi Sankyo share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Daiichi Sankyo is a Sell and believe this share price will rise from its current level to --.
-
What Is Daiichi Sankyo's Price Target?
The price target for Daiichi Sankyo over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is DSKYF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Daiichi Sankyo is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of DSKYF?
You can purchase shares of Daiichi Sankyo via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Daiichi Sankyo shares.
-
What Is The Daiichi Sankyo Share Price Today?
Daiichi Sankyo was last trading at $23.13 per share. This represents the most recent stock quote for Daiichi Sankyo. Yesterday, Daiichi Sankyo closed at $23.13 per share.
-
How To Buy Daiichi Sankyo Stock Online?
In order to purchase Daiichi Sankyo stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is MO dividend Worth It?
Altria Group (NYSE: MO) is paying investors $1.02 a share…
How High Will Take-Two Stock Go?
Take-Two Interactive (NASDAQ:TTWO) is the video game development company behind…
Stock Ideas
Buy
64
Is MSFT Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 40x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
83
GMS alert for Jun 23
GMS [GMS] is down 0.42% over the past day.
Buy
54
SMLR alert for Jun 23
Semler Scientific [SMLR] is up 7.17% over the past day.
Buy
57
GXO alert for Jun 23
GXO Logistics [GXO] is up 0.96% over the past day.
